Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme

The Journal of Biological Chemistry
Elizabeth A EckmanC Eckman

Abstract

Deposition of beta-amyloid (Abeta) peptides in the brain is an early and invariant feature of all forms of Alzheimer's disease. As with any secreted protein, the extracellular concentration of Abeta is determined not only by its production but also by its catabolism. A major focus of Alzheimer's research has been the elucidation of the mechanisms responsible for the generation of Abeta. Much less, however, is known about the mechanisms responsible for Abeta removal in the brain. In this report, we describe the identification of endothelin-converting enzyme-1 (ECE-1) as a novel Abeta-degrading enzyme. We show that treatment of endogenous ECE-expressing cell lines with the metalloprotease inhibitor phosphoramidon causes a 2-3-fold elevation in extracellular Abeta concentration that appears to be due to inhibition of intracellular Abeta degradation. Furthermore, we show that overexpression of ECE-1 in Chinese hamster ovary cells, which lack endogenous ECE activity, reduces extracellular Abeta concentration by up to 90% and that this effect is completely reversed by treatment of the cells with phosphoramidon. Finally, we show that recombinant soluble ECE-1 is capable of hydrolyzing synthetic Abeta40 and Abeta42 in vitro at multiple...Continue Reading

References

Jan 31, 1991·Biochemical and Biophysical Research Communications·T SawamuraT Masaki
Jun 1, 1990·Trends in Pharmacological Sciences·B P Roques, A Beaumont
Jan 1, 1980·Scandinavian Journal of Clinical and Laboratory Investigation·C Grönhagen-Riska, F Fyhrquist
Jan 1, 1995·Methods in Enzymology·P CorvolF Soubrier
Dec 15, 1995·The Journal of Biological Chemistry·O ValdenaireM G Mattei
Jan 26, 1996·Biochemical Pharmacology·A J Turner, L J Murphy
Apr 5, 1996·The Journal of Biological Chemistry·W Q QiuD J Selkoe
Jan 1, 1996·Pharmacology & Therapeutics·G A Gray, D J Webb
Apr 1, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A J Turner, K Tanzawa
Nov 14, 1997·The Biochemical Journal·M V Hoang, A J Turner
Feb 25, 1998·Biochemical and Biophysical Research Communications·K AhnM Yanagisawa
May 22, 1998·Journal of Cardiovascular Pharmacology·S TélémaqueM Yanagisawa
Jun 17, 1998·DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes·T NagaseO Ohara
Nov 26, 1998·The Journal of Biological Chemistry·W Q QiuD J Selkoe
Feb 5, 1999·Human Molecular Genetics·P KehoeM J Owen
Feb 6, 1999·The Journal of Biological Chemistry·G D JohnsonK Ahn
Mar 20, 1999·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·P KorthF Pinet
Jun 22, 1999·The Journal of Biological Chemistry·R YaminC R Abraham
May 17, 2000·The Journal of Clinical Investigation·H YanagisawaM Yanagisawa
May 18, 2000·Biochemical and Biophysical Research Communications·T OuimetO Tanja

❮ Previous
Next ❯

Citations

May 13, 2008·Cellular and Molecular Life Sciences : CMLS·E MalitoW-J Tang
Nov 27, 2007·Acta Neuropathologica·Charles DuyckaertsBenoît Delatour
Dec 8, 2009·Brain Structure & Function·Kanae Iijima-Ando, Koichi Iijima
May 26, 2005·Biochemical and Biophysical Research Communications·Laura MorelliEduardo M Castaño
Jul 18, 2002·Trends in Pharmacological Sciences·Diana Ines Dominguez, Bart De Strooper
Nov 24, 2001·Trends in Neurosciences·C G JansonM J During
Jul 20, 2002·Peptides·Geneviève Evin, Andreas Weidemann
Jul 31, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Niki C CartyDave Morgan
Jul 27, 2012·Metallomics : Integrated Biometal Science·Giuseppe GrassoEnrico Rizzarelli
Jun 18, 2002·Journal of Neurochemistry·Julie A Carson, Anthony J Turner
Aug 21, 2009·The Journal of Biological Chemistry·Mei-Chen LiaoWilliam E Van Nostrand
Oct 2, 2012·The Journal of Biological Chemistry·Chao WangLi Gan
Jan 4, 2013·The Journal of Biological Chemistry·Javier Pacheco-Quinto, Elizabeth A Eckman
Aug 30, 2008·The Journal of Biological Chemistry·Malcolm A Leissring
Jun 27, 2003·Journal of Cardiovascular Pharmacology·Daiji IsakaMasafumi Matsuo
Jun 8, 2012·Cold Spring Harbor Perspectives in Medicine·Takaomi Saido, Malcolm A Leissring
Jul 25, 2009·Molecular Neurodegeneration·Rina YaminCarmela R Abraham
Sep 19, 2012·Molecular Neurodegeneration·Samer O Abdul-HayMalcolm A Leissring
Jun 1, 2007·Biomarkers in Medicine·Ulf AndreassonHenrik Zetterberg
Jan 29, 2011·International Journal of Alzheimer's Disease·Taehyun KimDoo-Sup Choi
Oct 19, 2006·Journal of Biomedicine & Biotechnology·Deng-Shun WangJames S Malter
Apr 7, 2004·Médecine sciences : M/S·Florence Pinet
Jan 12, 2005·The Journal of Cell Biology·Edward B LeeVirginia M-Y Lee
Jun 27, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Antonio TorselloVittorio Locatelli
Dec 30, 2015·Acta Neuropathologica·Seth Love, J Scott Miners
Oct 18, 2011·Journal of Neuropathology and Experimental Neurology·James Scott MinersSeth Love
Aug 22, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Shingo ItoTetsuya Terasaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.